Chief Executive Officer, Definium Therapeutics
Appears in 1 story
Leading two Phase 3 anxiety trials and a depression program
A single dose of LSD, taken as a tablet that dissolves under the tongue, cut anxiety scores for people with generalized anxiety disorder and held that benefit for 12 weeks. On August 12, 2026, Definium Therapeutics said its drug, DT120, beat placebo in its first large late-stage trial. The effect showed up by day two.
Updated 2 hours ago
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
